Evidence map›Paper›PMID 25351777›Full record

ArticleEuropean journal of human genetics : EJHG2015

Detection of TRIM32 deletions in LGMD patients analyzed by a combined strategy of CGH array and massively parallel sequencing.

Juliette Nectoux, Rafael de Cid, Sylvain Baulande, France Leturcq, Jon Andoni Urtizberea, Isabelle Penisson-Besnier, Aleksandra Nadaj-Pakleza, Carinne Roudaut, Audrey Criqui, Lucie Orhant and 13 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. TheActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. eLife · 2020
    Article
  7. Extending the clinical and mutational spectrum ofJournal of neurology, neurosurgery, and psychiatry · 2019
    Article
  8. NovelActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Juliette Nectoux1] Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, France [2] UMR 8104, Inserm U1016, Université Paris Descartes, Institut Cochin, Laboratoire de Génétique des Maladies Neurodéveloppementales, Paris, France.
Rafael de CidGénéthon - UMR8587 LAMBE, Evry, France.
Sylvain BaulandeGénopole Campus 2, PartnerChip, Evry, France.
France Leturcq1] Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, France [2] Sorbonne Universités, UPMC Univ Paris 06, INSERM U974, CNRS FRE 3617, Center of Research in Myology, Institut de Myologie, Paris, France.
Jon Andoni UrtizbereaHôpital Marin, Centre de référence neuromusculaire GNMH, Hendaye, France.
Isabelle Penisson-BesnierCHU Angers, Département de Neurologie, Angers, France.
Aleksandra Nadaj-PaklezaCHU Angers, Département de Neurologie, Angers, France.
Carinne RoudautGénéthon - UMR8587 LAMBE, Evry, France.
Audrey CriquiGénopole Campus 2, PartnerChip, Evry, France.
Lucie OrhantAssistance Publique-Hôpitaux de Paris, Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, France.
Delphine PeyroulanCHRU Montpellier, Laboratoire de Génétique moléculaire, Montpellier, France.
Raba Ben YaouSorbonne Universités, UPMC Univ Paris 06, INSERM U974, CNRS FRE 3617, Center of Research in Myology, Institut de Myologie, Paris, France.
Isabelle NelsonSorbonne Universités, UPMC Univ Paris 06, INSERM U974, CNRS FRE 3617, Center of Research in Myology, Institut de Myologie, Paris, France.
Anna Maria CoboHôpital Marin, Centre de référence neuromusculaire GNMH, Hendaye, France.
Marie-Christine Arné-BesCHU Toulouse, Centre de référence neuromusculaire, Toulouse, France.
Emmanuelle Uro-CosteCHU Toulouse, Centre de référence neuromusculaire, Toulouse, France.
Patrick NitschkeUniversité Paris Descartes, Plateforme de Bioinformatique, Paris, France.
Mireille Claustres1] CHRU Montpellier, Laboratoire de Génétique moléculaire, Montpellier, France [2] Inserm U827, Université Montpellier 1, Laboratoire de Génétique de Maladies rares, Montpellier, France.
Gisèle Bonne1] Sorbonne Universités, UPMC Univ Paris 06, INSERM U974, CNRS FRE 3617, Center of Research in Myology, Institut de Myologie, Paris, France [2] Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, U.F. Cardiogénétique et Myogénétique, Service de Biochimie Métabolique, Paris, France.
Nicolas LévyInserm UMR_S910, Université de la Méditerranée, Génétique médicale & Génomique Fonctionnelle, Marseille, France.
Jamel Chelly1] Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, France [2] UMR 8104, Inserm U1016, Université Paris Descartes, Institut Cochin, Laboratoire de Génétique des Maladies Neurodéveloppementales, Paris, France.
Isabelle RichardGénéthon - UMR8587 LAMBE, Evry, France.
Mireille Cossée1] CHRU Montpellier, Laboratoire de Génétique moléculaire, Montpellier, France [2] Inserm U827, Université Montpellier 1, Laboratoire de Génétique de Maladies rares, Montpellier, France.
Inserm · FRCentre National de la Recherche Scientifique · FRLaboratoire Analyse et Modélisation pour la Biologie et l'Environnement · FRCentre Hospitalier Universitaire d'Angers · FRGenopole (France) · FRHôpital Marin de Hendaye · FRHôpital Cochin · FRInstitut de Génétique Moléculaire de Montpellier · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defects in TRIM32 were reported in limb-girdle muscular dystrophy type 2H (LGMD2H), sarcotubular myopathies (STM) and in Bardet-Biedl syndrome. Few cases have been described to date in LGMD2H/STM, but this gene is not systematically analysed because of the absence of specific signs and difficulties in protein analysis. By using high-throughput variants screening techniques, we identified variants in TRIM32 in two patients presenting nonspecific LGMD. We report the first case of total inactivation by homozygous deletion of the entire TRIM32 gene. Of interest, the deletion removes part of the ASTN2 gene, a large gene in which TRIM32 is nested. Despite the total TRIM32 gene inactivation, the patient does not present a more severe phenotype. However, he developed a mild progressive cognitive impairment that may be related to the loss of function of ASTN2 because association between ASTN2 heterozygous deletions and neurobehavioral disorders was previously reported. Regarding genomic characteristics at breakpoint of the deleted regions of TRIM32, we found a high density of repeated elements, suggesting a possible hotspot. These observations illustrate the importance of high-throughput technologies for identifying molecular defects in LGMD, confirm that total loss of function of TRIM32 is not associated with a specific phenotype and that TRIM32/ASTN2 inactivation could be associated with cognitive impairment.

Indexed as

Gene DeletionAdultBase SequenceComparative Genomic HybridizationDNA Mutational AnalysisFamily HealthFemaleHigh-Throughput Nucleotide SequencingHumansMaleMuscular Dystrophies, Limb-GirdlePedigreeTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesTranscription FactorsTRIM32 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID25351777
PMCPMC4463509
OpenAlexW1970850160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.